Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with huntington's disease

Yen Chu Huang, Yih Ru Wu, Mu Yun Tseng, Yi Chun Chen, Sen Yung Hsieh, Chiung Mei Chen*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

47 Scopus citations

Abstract

Huntington's disease (HD) is a progressive neurodegenerative disease caused by an unstable CAG trinucleotide repeat expansion. The need for biomarkers of onset and progression in HD is imperative, since currently reliable outcome measures are lacking. We used two-dimensional electrophoresis and mass spectrometry to analyze the proteome profiles in cerebrospinal fluid (CSF) of 6 pairs of HD patients and controls. Prothrombin, apolipoprotein A-IV (Apo A-IV) and haptoglobin were elevated in CSF of the HD patients in comparison with the controls. We used western blot as a semiquantified measurement for prothrombin and Apo A-IV, as well as enzyme linked immunosorbent assay (ELISA) for measurement of haptoglobin, in 9 HD patients and 9 controls. The albumin quotient (Qalb), a marker of blood-brain barrier (BBB) function, was not different between the HD patients and the controls. The ratios of CSF prothrombin/albumin (prothrombin/Alb) and Apo A-IV/albumin (Apo A-IV/Alb), and haptoglobin level were significantly elevated in HD. The ratio of CSF prothrombin/Alb significantly correlated with the disease severity assessed by Unified Huntington's Disease Rating Scale (UHDRS). The results implicate that increased CSF prothrombin, Apo A-IV, and haptoglobin may be involved in pathogenesis of HD and may serve as potential biomarkers for HD.

Original languageEnglish
Article numbere15809
JournalPLoS ONE
Volume6
Issue number1
DOIs
StatePublished - 2011

Fingerprint

Dive into the research topics of 'Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with huntington's disease'. Together they form a unique fingerprint.

Cite this